Patents by Inventor Wen-Bin Chung

Wen-Bin Chung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834647
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: December 5, 2023
    Assignee: National Pingtung University of Science and Technology
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Publication number: 20230074637
    Abstract: The present invention relates to a recombinant antigen and an isolated polynucleotide of porcine reproductive and respiratory syndrome virus (PRRSV), a composition including the same and a method of making the same. The recombinant antigen is a chimeric protein of PRRSV dual structural proteins and T-cell epitope. The polynucleotide encodes an amino acid sequence of the recombinant antigen. The recombinant protein expressed by the polynucleotide in an eukaryotic expression system can be beneficial for mass production and purification. An immunogenic composition including the recombinant antigen can promote pro-inflammatory M1-phenotype polarization of porcine alveolar macrophages (PAMs), reduce receptor CD163 expression that is mediated for viral entry and activate T helper (Th1) immune responses, thereby being applied to a vaccine composition against PRRSV.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 9, 2023
    Inventors: Hso-Chi Chaung, Ko-Tung Chang, Mei-Li Wu, Wen-Bin Chung
  • Publication number: 20200407683
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 31, 2020
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Publication number: 20200190471
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 18, 2020
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Patent number: 8008031
    Abstract: The present invention provides a method for detecting a beta-glucan having immunomodulatory activity in a human cell, which uses a test cell line that stably expresses human dectin-1 molecule on the cell surface and does not express other glucan receptors and a specific amount of a marker beta-glucan that specifically binds to human dectin-1 molecule for detection.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: August 30, 2011
    Assignee: National Pingtung University of Science and Technology
    Inventors: Mei-Li Wu, Hso-Chi Chaung, Tzou-Chi Huang, Wen-Bin Chung, Hui-Ju Hung
  • Publication number: 20090162872
    Abstract: The present invention provides a method for detecting a beta-glucan having immunomodulatory activity in a human cell, which uses a test cell line that stably expresses human dectin-1 molecule on the cell surface and does not express other glucan receptors and a specific amount of a marker beta-glucan that specifically binds to human dectin-1 molecule for detection.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 25, 2009
    Inventors: Mei-Li WU, Hso-Chi CHAUNG, Tzou-Chi HUANG, Wen-Bin CHUNG, Hui-Ju HUNG
  • Publication number: 20040117229
    Abstract: A system and method of automated repair and control operation. First, RMA numbers are generated after RMA request forms for returned product are received. RMA data for the returned product is uploaded to a database of a factory information system and is then verified for accuracy. Next, it is determined whether claimed defects of the returned product are accurate and the returned product are repaired accordingly. Returned product are inspected again to confirm the repairing step is complete, and finally, packaged and shipped.
    Type: Application
    Filed: December 9, 2003
    Publication date: June 17, 2004
    Inventors: Wen-Bin Chung, Han-Cheng Lai, Shih-Chi Pan